Skip to content

QS Supplements

Active
Private limited companyfounded 2022active for 4 yearsTen Boschstraat 18, 2650 Edegem, BelgiumKBO/BCE: BE 0790.861.982
Summary

The computed 12-month bankruptcy probability of QS Supplements is 4.2% (elevated). The 2025 annual accounts show negative equity (-€92,056) and a net result of -€69,411. Equity is shrinking by about 235% per year across the filed financial years. Its solvency ranks better than 9% of 13,511 sector peers (NACE 46, financial year 2025). The company has been active since 2022 and the Belgian Official Gazette contains no insolvency or warning signals.

History

On 15 September 2022, QS Supplements was incorporated as a private limited company.1 In 2025 the registered office moved to Edegem.2 Total assets went from €62,742 in 2023 to €91,588 in 2025.3

  1. 1KBO register
  2. 2Belgian Official Gazette, 24-02-2025
  3. 3National Bank, annual accounts 2023 and 2025

Acts, filings and financial milestones

Next filing, financial year 2026, expected by 31-07-2027
2026
30-06
NBB filing Annual accounts filed
financial year 2025 · micro format
2025
31-12
Financial Weakest financial yearnet -€69,411
Net result drops to -€69,411, the lowest in the series.
03-06
NBB filing Annual accounts filed
financial year 2024 · micro format
24-02
Gazette deed Permanent representatives: Blankaert István and Blankckaert István
Registered-office move5 facts ▸
  • Board meeting, 08-01-2025
  • Registered-office move, Ten Boschstraat 18, 2650 Edegem
  • Permanent representative, Blankaert István
  • Permanent representative, Blankckaert István
  • Other provision, “Bestuurder, signatory capacity” (deed in Dutch)
2024
01-07
NBB filing Annual accounts filed
financial year 2023 · micro format
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
1 of 2 deeds read
About the unread acts

Of the 2 Belgian Official Gazette deeds we know for this company, 1 has been read. The other one has not been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.